Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.
about
Complete hepatitis B virus genome analysis in HBsAg positive mothers and their infants with fulminant hepatitis BCorrelations of HBV genotypes, mutations affecting HBeAg expression and HBeAg/ anti-HBe status in HBV carriers.Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi.A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population.A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice.Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression.HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.The core promoter of hepatitis B virus.Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor.Replication of the wild type and a natural hepatitis B virus nucleocapsid promoter variant is differentially regulated by nuclear hormone receptors in cell culture.Critical roles of nuclear receptor response elements in replication of hepatitis B virus.Chimeric constructs between two hepatitis B virus genomes confirm transcriptional impact of core promoter mutations and reveal multiple effects of core gene mutations.Hepatitis B virus genotypes and precore and core mutants in UAE patientsCoexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses.Acute liver failure: established and putative hepatitis viruses and therapeutic implications.Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinomaWorld-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants.Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion.Hepatitis B virus genetic variants: biological properties and clinical implicationsOverview of hepatitis B viral replication and genetic variabilityApplication of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus.The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis.Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach.Hepatocellular carcinoma: the point of view of the hepatitis B virus.Core promoter: a critical region where the hepatitis B virus makes decisions.Influence of the basal core promoter and precore mutation on replication of hepatitis B virus and antiviral susceptibility of different genotypes.Enrichment of a precore-minus mutant of duck hepatitis B virus in experimental mixed infections.Fatal fulminant hepatitis caused by infection with subgenotype A1 hepatitis B virus with C1766T/T1768A core promoter mutations.Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection.Hepatitis B virus: prevalence of precore/core promoter mutants in different clinical categories of Indian patients.Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients.Molecular, immunological and clinical properties of mutated hepatitis B viruses.Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients.Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy.Successful establishment and evaluation of a new animal model for studying the hepatitis B virus YVDD mutant.A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg-negative chronic hepatitis B in China.An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringes.
P2860
Q24793897-740DEF1A-C412-4827-9B98-F9DCD7B8AAF1Q25256535-BFC935A5-FB4B-4944-B2F2-F975FFE2C473Q33251555-04016C6C-9BFB-439B-8D24-993B08CE8AD4Q33313034-248C1E75-5D0B-479A-84DE-9B6FF197814CQ33585283-926F046E-133A-4A8B-ADF6-830A3104C5F6Q33783630-DF17D2C2-C3A5-4338-B6B9-FF822C1ED36BQ33801305-FDB95564-B772-4619-AD49-CFCF1F9CE8DEQ33801359-E112DB58-A3D1-407A-8DAE-0268789C243AQ33824213-AD256946-B477-40B4-900B-87F3967981F9Q33845008-C12B0A55-8FD3-4249-9392-77DAD4749696Q33849658-FF42C230-2E57-437A-8425-89B313256F8EQ33944550-5307DF91-0480-4825-B9EC-B343C8CF306AQ34036064-BFF41277-A861-41CC-9B9B-BDB840BB23FFQ34057979-331369AF-5C37-4424-94F0-5CD36F466F0BQ34095674-381104D0-A41A-4855-8DCC-FEDEF8C2879EQ34514581-4F5617E0-6C26-4E53-8D21-47AC7EE4D8C8Q34536159-C49BCCF7-F144-4470-9EA0-AE46B235A122Q35020504-62D6EBD1-E83E-4805-A791-AE0AE840F4EAQ35840358-0F0E88D6-E97B-4996-A8D4-D05B0F0422E8Q36795324-4C47E7BF-E381-4FA1-A5E0-223D00019FABQ36807341-2F82DB52-244F-4A92-AA02-3017C93A330DQ36845456-AAF4D3BE-65C0-410D-A06E-8A6C48793EE4Q37111755-292C197D-6D3E-4780-8655-05027327C24EQ37285249-28A838E6-748E-4226-B032-43033E24D240Q37888329-065C81D4-D5A6-4C96-A011-E301FB19E3A3Q38191563-89A2FFB4-784E-4C70-A971-495A06610377Q38917530-FB32CDDA-26A8-4F81-BC9C-8732885EF4A7Q39550275-108FDC1F-5D68-430F-89AB-E0D515DB3F82Q40680143-23B3E638-3F51-4EF2-9885-31136CC8AD40Q41527993-D4AFDDAF-0982-4963-A391-E2AC0E6DC819Q42447429-9F4B3E82-34D9-423A-BE89-F5F9794A866EQ42494265-450A2017-A87F-4F59-8C95-8FA6AA909783Q43831214-2BADFCA8-BE23-47C6-95D4-3A827EC4E570Q43988430-7B0CBA6C-C2D4-43AF-8DC9-C1616C809502Q43993353-E0B74668-4313-4974-B511-7A7AE8AC1C6EQ44712613-A45AF275-665E-433F-BD93-7C48832886D6Q45168079-FC3D7F71-F0BA-4C1F-863A-EE3A6124DA6BQ45353741-02D1DE2D-B818-4FED-B835-B91C5E43FCBDQ45397200-542AB962-5D7C-4B6B-8A94-0DEFA0EF3224Q45404213-B39C516E-3001-42FF-8306-647F93E87A76
P2860
Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Reduced precore transcription ...... egative persistent infections.
@en
type
label
Reduced precore transcription ...... egative persistent infections.
@en
prefLabel
Reduced precore transcription ...... egative persistent infections.
@en
P2093
P356
P1433
P1476
Reduced precore transcription ...... negative persistent infections
@en
P2093
P304
P356
10.1006/VIRO.1996.0655
P407
P577
1996-12-01T00:00:00Z